Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: a 24-week prospective study.
about
Antiretroviral medication: an emerging category of prescription drug misuseEfavirenz and the CNS: what we already know and questions that need to be answeredInfluence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 InfectionThe Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 InfectionNeurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and TreatmentEvaluating sleep and cognition in HIVImplications of efavirenz for neuropsychiatry: a review.A systematic review of the psychiatric side-effects of efavirenz.Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia.Histological effects of chronic administration of efavirenz on lateral geniculate body of adult Wistar rats8-Hydroxy-efavirenz, the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes.Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults.HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz.
P2860
Q26852974-CD1C9359-60A5-485C-91D3-A7E4073C6D55Q28085028-7E1D38FD-EC55-410F-98F9-EB62B97A452EQ34756398-27930890-0153-4C03-AE22-CFB881AA0FF9Q34976284-C91BA31A-7BE7-4192-BB82-94F5FA355271Q35111300-598AC819-3BC6-479E-A59F-6115AF8CA945Q36330202-C5195CDC-5FF5-4A00-A30F-90B6464BAAC7Q37294737-81B424EE-48B7-4BDD-9776-8A76934CD35EQ37801927-D1EBEFD1-9C0E-4E1F-A713-7E74131DE363Q37864141-FFA77EFF-C4B2-4A82-9B9D-0BBAE47B5E3EQ37900614-951C961C-4ED7-4CA2-A10E-AFCF93AF254AQ41203661-9E09C5A8-A4FE-466D-B7B3-7B97492812C4Q42070976-40FC5272-1556-466B-ADF7-C82B82B43CBCQ43419116-B4D511E2-28EF-44DD-8556-54FC0148EA0FQ55169028-A851844E-1599-47CF-8AA7-5E1F881EE642Q55344050-5638D7A4-B8D9-4FA1-8B51-5331FC29D534
P2860
Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: a 24-week prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@en
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@nl
type
label
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@en
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@nl
prefLabel
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@en
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@nl
P2093
P2860
P356
P1476
Adverse drug reactions to nonn ...... : a 24-week prospective study.
@en
P2093
Ajay Wanchu
Aman Sharma
Anupam Jena
Ravinder K Sachdeva
P2860
P304
P356
10.1177/1545109709343967
P577
2009-08-31T00:00:00Z